These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 30408615)

  • 1. Relationship Between Anaphylaxis and Use of Beta-Blockers and Angiotensin-Converting Enzyme Inhibitors: A Systematic Review and Meta-Analysis of Observational Studies.
    Tejedor-Alonso MA; Farias-Aquino E; Pérez-Fernández E; Grifol-Clar E; Moro-Moro M; Rosado-Ingelmo A
    J Allergy Clin Immunol Pract; 2019 Mar; 7(3):879-897.e5. PubMed ID: 30408615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher versus lower doses of ACE inhibitors, angiotensin-2 receptor blockers and beta-blockers in heart failure with reduced ejection fraction: Systematic review and meta-analysis.
    Turgeon RD; Kolber MR; Loewen P; Ellis U; McCormack JP
    PLoS One; 2019; 14(2):e0212907. PubMed ID: 30817783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk for Anaphylactic Reaction from Cardiac Catheterization in Patients Receiving β-Adrenergic Blockers or Angiotensin-Converting Enzyme-Inhibitors.
    Smith MA; Newton LP; Barcena Blanch MA; Cuervo-Pardo L; Cho L; Newton D; Wang X; Li M; Lang DM
    J Allergy Clin Immunol Pract; 2020 Jun; 8(6):1900-1905. PubMed ID: 31683029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of Trastuzumab and Anthracycline-induced Cardiotoxicity Using Angiotensin-converting Enzyme Inhibitors or β-blockers in Older Adults With Breast Cancer.
    Wittayanukorn S; Qian J; Westrick SC; Billor N; Johnson B; Hansen RA
    Am J Clin Oncol; 2018 Sep; 41(9):909-918. PubMed ID: 28537988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin-converting enzyme inhibitors/angiotensin receptor blockers therapy and colorectal cancer: a systematic review and meta-analysis.
    Dai YN; Wang JH; Zhu JZ; Lin JQ; Yu CH; Li YM
    Cancer Causes Control; 2015 Sep; 26(9):1245-55. PubMed ID: 26081426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angioedema Among Hypertensive Patients Treated with Aliskiren or Other Antihypertensive Medications in the United States.
    Schlienger RG; Korn JR; Wehler E; Lopez Leon S; Yeaw J
    Am J Cardiovasc Drugs; 2017 Dec; 17(6):465-474. PubMed ID: 28779444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The development of new-onset type 2 diabetes associated with choosing a calcium channel blocker compared to a diuretic or beta-blocker.
    Kuti EL; Baker WL; White CM
    Curr Med Res Opin; 2007 Jun; 23(6):1239-44. PubMed ID: 17559720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative risk for angioedema associated with the use of drugs that target the renin-angiotensin-aldosterone system.
    Toh S; Reichman ME; Houstoun M; Ross Southworth M; Ding X; Hernandez AF; Levenson M; Li L; McCloskey C; Shoaibi A; Wu E; Zornberg G; Hennessy S
    Arch Intern Med; 2012 Nov; 172(20):1582-9. PubMed ID: 23147456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin converting enzyme inhibitors effect on arterial stiffness and wave reflections: a meta-analysis and meta-regression of randomised controlled trials.
    Shahin Y; Khan JA; Chetter I
    Atherosclerosis; 2012 Mar; 221(1):18-33. PubMed ID: 22209214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on all-cause mortality, cardiovascular deaths, and cardiovascular events in patients with diabetes mellitus: a meta-analysis.
    Cheng J; Zhang W; Zhang X; Han F; Li X; He X; Li Q; Chen J
    JAMA Intern Med; 2014 May; 174(5):773-85. PubMed ID: 24687000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Updates on the treatment of essential hypertension: a summary of AHRQ's comparative effectiveness review of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and direct renin inhibitors.
    Powers B; Greene L; Balfe LM
    J Manag Care Pharm; 2011 Oct; 17(8 Suppl):S1-14. PubMed ID: 22088101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin converting enzyme inhibitors effect on endothelial dysfunction: a meta-analysis of randomised controlled trials.
    Shahin Y; Khan JA; Samuel N; Chetter I
    Atherosclerosis; 2011 May; 216(1):7-16. PubMed ID: 21411098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on cardiovascular events in patients with heart failure: a meta-analysis of randomized controlled trials.
    Tai C; Gan T; Zou L; Sun Y; Zhang Y; Chen W; Li J; Zhang J; Xu Y; Lu H; Xu D
    BMC Cardiovasc Disord; 2017 Oct; 17(1):257. PubMed ID: 28982370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihypertensive medication use is associated with increased organ system involvement and hospitalization in emergency department patients with anaphylaxis.
    Lee S; Hess EP; Nestler DM; Bellamkonda Athmaram VR; Bellolio MF; Decker WW; Li JT; Hagan JB; Manivannan V; Vukov SC; Campbell RL
    J Allergy Clin Immunol; 2013 Apr; 131(4):1103-8. PubMed ID: 23453138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-converting enzyme inhibitors do not impair the safety of Hymenoptera venom immunotherapy build-up phase.
    Stoevesandt J; Hain J; Stolze I; Kerstan A; Trautmann A
    Clin Exp Allergy; 2014; 44(5):747-55. PubMed ID: 24447144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renin-angiotensin system blockade does not attenuate abdominal aortic aneurysm growth, rupture rate, or perioperative mortality after elective repair.
    Salata K; Syed M; Hussain MA; Eikelboom R; de Mestral C; Verma S; Al-Omran M
    J Vasc Surg; 2018 Feb; 67(2):629-636.e2. PubMed ID: 29175038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renin-angiotensin system inhibitors linked to anemia: a systematic review and meta-analysis.
    Cheungpasitporn W; Thongprayoon C; Chiasakul T; Korpaisarn S; Erickson SB
    QJM; 2015 Nov; 108(11):879-84. PubMed ID: 25697787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ten-year trends of cardiovascular drug use after myocardial infarction among community-dwelling persons > or =65 years of age.
    Setoguchi S; Glynn RJ; Avorn J; Levin R; Winkelmayer WC
    Am J Cardiol; 2007 Oct; 100(7):1061-7. PubMed ID: 17884362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular outcomes in high-risk patients without heart failure treated with ARBs: a systematic review and meta-analysis.
    Al Khalaf MM; Thalib L; Doi SA
    Am J Cardiovasc Drugs; 2009; 9(1):29-43. PubMed ID: 19178130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drugs as risk factors of food anaphylaxis in adults].
    Moneret-Vautrin DA
    Med Sci (Paris); 2010; 26(8-9):719-23. PubMed ID: 20819708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.